News

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission tomography (PET) radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

Time September 26, 2013
Home
Feature

When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.

Time September 26, 2013
Home
News

The ASRT Foundation and RAD-AID International have announced plans to offer a program for radiation therapists to teach in China.

Time September 26, 2013
Home
Technology

At the 55th American Society for Radiation Oncology (ASTRO) annual meeting, September 22-25 in Atlanta, Royal Philips featured the latest innovations that address efficient and personalized radiation oncology care for patients and their clinicians.

Time September 26, 2013
Home
News

Accuray Inc. announced its momentum in gaining adoption for both the new CyberKnife M6 Series and TomoTherapy H Series Systems at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting taking place at the Georgia World Congress Center in Atlanta. Through presentations from leading radiation oncology practitioners and product demonstrations, attendees can gain further knowledge on the clinical capabilities of the CyberKnife M6 Series and TomoTherapy H Series Systems introduced at last year’s ASTRO meeting.

Time September 25, 2013
Home
Feature

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity.

Time September 25, 2013
Home
Technology

iCAD Inc. has announced a strategic alliance with DermEbx to offer the Xoft Axxent Electronic Brachytherapy System to treat non-melanoma skin cancer (NMSC) throughout the DermEbx network of dermatology centers.

Time September 25, 2013
Home
Technology

Sensus Healthcare has announced its newest introduction for non-melanoma skin cancer treatment at the 55th annual American Society of Therapeutic Radiation Oncology (ASTRO) in Atlanta, Ga. Sensus has an advanced SRT-100 superficial radiotherapy platform, featuring SharpBeam and has introduced the recently FDA-cleared technology that now allows you to "See what you Treat."

Time September 25, 2013
Home
Technology

Mirada Medical has formalized an agreement with General Electric Healthcare, Milwaukee, Wis., whereby GE will license Mirada’s powerful automatic atlas-based contouring software for implementation on their AdvantageSim MD 9 virtual simulation software suite for advanced radiation therapy planning. The technology is based on Mirada Medical’s deformable registration software, which is widely regarded as best in class when aligning image data for RT planning.

Time September 25, 2013
Home
Feature

An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also suggests that lung cancer patients who received intensity modulated radiation therapy (IMRT) reported less decline in their QOL compared to those receiving three-dimensional conformal radiation therapy (3-D CRT).

Time September 25, 2013
Home
News

Cianna Medical Inc., announced results of two new studies showing excellent longer-term outcomes with the SAVI breast brachytherapy applicator, including low recurrence rates, few toxicities, excellent cosmetic outcomes and high rates of survival. A third study demonstrated SAVI’s ability to precisely deliver radiation while avoiding critical structures. SAVI is a strut-based applicator that delivers accelerated partial breast irradiation (APBI), a five-day course of targeted radiation for early-stage breast cancer.

Time September 25, 2013
Home
News

IBA (Ion Beam Applications S.A.) has launched an extension to the Visicoil product line at the annual ASTRO congress of the American Society for Radiation Oncology. This new design incorporates kV X-ray imaging compliant Visicoil Linear Markers pre-loaded in 21g and 22g needles that are almost half the size of needles typically used for placement of gold seeds.

Time September 24, 2013
Home
Feature

A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented at the American Society for Radiation Oncology’s (ASTRO) 55th Annual Meeting. The study confirmed a disease-specific-survival (DSS) rate of 95 percent when patients received fewer weeks of neoadjuvant (NEO) total androgen suppression (TAS).

Time September 24, 2013
Home
Feature

GE Healthcare reported that Silent Scan, a revolutionary technology that dramatically quiets magnetic resonance imaging (MRI) exams, is now commercially available and growing in clinical adoption around the world. Silent Scan addresses one of the most significant impediments to patient comfort — excessive acoustic noise generated during an MRI scan. Conventional MRI scanners can generate noise in excess of 110 decibels, roughly equivalent to rock concerts and requiring ear protection. GE’s exclusive Silent Scan technology is designed to reduce MR scanner noise to ambient (background) sound levels and improve a patient’s MRI exam experience.

Time September 24, 2013
Home
Feature

When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT.

Time September 24, 2013
Home
News

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.

Time September 24, 2013
Home
News

Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO).

Time September 24, 2013
Home
Technology

Nucletron, an Elekta company has launched Esteya, a new approach for treating patients with skin cancer.

Time September 24, 2013
Home
Technology

Elekta has introduced Monaco 5.0, which consolidates support for clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision.

Time September 24, 2013
Home
News

This August marked the 10th anniversary of the first production use of TeraMedica’s Evercore vendor neutral archive software.

Time September 23, 2013
Home
Subscribe Now